Shoulder Innovations (SI) Competitors

Embecta (NASDAQ:EMBC) and Shoulder Innovations (NYSE:SI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

Is EMBC or SI a better dividend stock?

Embecta pays an annual dividend of $0.60 per share and has a dividend yield of 4.0%. Shoulder Innovations pays an annual dividend of $2.9420 per share and has a dividend yield of 19.7%. Embecta pays out 42.0% of its earnings in the form of a dividend. Shoulder Innovations pays out -9.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Shoulder Innovations is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do analysts prefer EMBC or SI?

Embecta presently has a consensus target price of $19.00, indicating a potential upside of 25.99%. Shoulder Innovations has a consensus target price of $19.60, indicating a potential upside of 30.93%. Given Shoulder Innovations' stronger consensus rating and higher possible upside, analysts plainly believe Shoulder Innovations is more favorable than Embecta.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Shoulder Innovations	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Which has better earnings and valuation, EMBC or SI?

Embecta has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.12B	0.79	$78.30M	$1.43	10.55
Shoulder Innovations	$34.57M	6.59	-$456.26M	-$29.96	-0.50

Do insiders & institutionals believe in EMBC or SI?

93.8% of Embecta shares are owned by institutional investors. 0.4% of Embecta shares are owned by insiders. Comparatively, 1.7% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is EMBC or SI more profitable?

Embecta has a net margin of 7.58% compared to Shoulder Innovations' net margin of 0.00%. Shoulder Innovations' return on equity of 0.00% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	7.58%	-23.40%	14.46%
Shoulder Innovations	N/A	N/A	N/A

Does the media refer more to EMBC or SI?

In the previous week, Shoulder Innovations had 6 more articles in the media than Embecta. MarketBeat recorded 11 mentions for Shoulder Innovations and 5 mentions for Embecta. Embecta's average media sentiment score of 1.07 beat Shoulder Innovations' score of 0.12 indicating that Embecta is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Shoulder Innovations	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Embecta and Shoulder Innovations tied by winning 9 of the 18 factors compared between the two stocks.